The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125624611 12562461 1 I 20160303 20160609 20160715 20160715 EXP US-SAOL THERAPEUTICS-2016SAO00175 SAOL THERAPEUTICS 47.33 YR F Y 104.31000 KG 20160715 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125624611 12562461 1 PS BACLOFEN. BACLOFEN 1 Intrathecal 500 ?G, DAY 411800 UG Y 20075 500 UG INJECTION QD
125624611 12562461 2 SS BACLOFEN. BACLOFEN 1 Intrathecal 550 ?G, DAY 411800 UG Y 20075 550 UG INJECTION QD
125624611 12562461 3 SS BACLOFEN. BACLOFEN 1 549.6 ?G, DAY 411800 UG Y 20075 549.6 UG INJECTION QD
125624611 12562461 4 SS MORPHINE MORPHINE 1 Intrathecal 0.49 MG, DAY Y 0 .49 MG QD
125624611 12562461 5 C ALPRAZOLAM. ALPRAZOLAM 1 0.5 MG, 2X/DAY 0 .5 MG BID
125624611 12562461 6 C CITALOPRAM CITALOPRAM HYDROBROMIDE 1 20 MG, 1X/DAY 0 20 MG QD
125624611 12562461 7 C FERROUS SULFATE. FERROUS SULFATE 1 325 MG, 1X/DAY 0 325 MG QD
125624611 12562461 8 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 1 DOSAGE UNITS, 2X/DAY 0 1 DF BID
125624611 12562461 9 C GABAPENTIN. GABAPENTIN 1 1200 MG, 3X/DAY 0 1200 MG TID
125624611 12562461 10 C METFORMIN METFORMIN HYDROCHLORIDE 1 500 MG, 1X/DAY 0 500 MG QD
125624611 12562461 11 C NITROFURANTOIN. NITROFURANTOIN 1 50 MG, 1X/DAY 0 50 MG QD
125624611 12562461 12 C OMEPRAZOLE. OMEPRAZOLE 1 40 MG, 1X/DAY 0 40 MG QD
125624611 12562461 13 C WARFARIN WARFARIN 1 4 MG, 1X/DAY 0 4 MG QD
125624611 12562461 14 C ALBUTEROL. ALBUTEROL 1 2 DOSAGE UNITS, AS NEEDED 0 2 DF
125624611 12562461 15 C BUPROPION. BUPROPION 1 150 MG, 1X/DAY 0 150 MG QD
125624611 12562461 16 C TIZANIDINE. TIZANIDINE 1 UNK MG, UNK 0
125624611 12562461 17 C NASONEX MOMETASONE FUROATE 1 1 DOSAGE UNITS, AS NEEDED 0 1 DF

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125624611 12562461 1 Muscle spasticity
125624611 12562461 4 Pain

Outcome of event

Event ID CASEID OUTC COD
125624611 12562461 DE
125624611 12562461 HO
125624611 12562461 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125624611 12562461 Acidosis
125624611 12562461 Central pain syndrome
125624611 12562461 Hyperkalaemia
125624611 12562461 Hypothermia
125624611 12562461 Hypoxic-ischaemic encephalopathy
125624611 12562461 Muscle spasms
125624611 12562461 Myoclonus
125624611 12562461 Overdose
125624611 12562461 Pain
125624611 12562461 Respiratory failure
125624611 12562461 Sepsis
125624611 12562461 Septic shock
125624611 12562461 Toxicity to various agents
125624611 12562461 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125624611 12562461 1 20131203 20160216 0
125624611 12562461 2 20160216 20160302 0
125624611 12562461 3 20160302 0
125624611 12562461 4 20160302 0